No insider purchases or sales are on record for Galera Therapeutics, Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-09-06.
Showing the most recent few. Create a free account to see 36 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.
no 13F holders found for this ticker
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| OPERATING INCOME | $-2.5M | $-20.2M | $-49.3M | $-51.2M |
| NET INCOME | $149.0M | $-19.0M | $-59.1M | $-62.2M |
| EPS (DILUTED) | 0.64 | -0.34 | -1.33 | — |
| OPERATING CASH FLOW | $-6.0M | $-12.1M | $-44.8M | $-43.4M |
| CASH | $6.4M | $8.3M | $18.3M | $4.3M |
No password to create and no card required. We store your email address and nothing else.